Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 2, 1999, Pages 149-152

  Stepanshina, V N ^a   Panfertsev, E A ^a   Korobova, O V ^a   Shemyakin, I G ^a   Stepanshin, Yu G ^a   Medvedeva, I M ^b   Dorozhkova, I R ^b  

^a STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

M. tuberculosis; Multidrug resistance; Rifampicin resistance

Indexed keywords

BACTERIAL DNA; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA SEQUENCE; FEMALE; HUMAN; KIDNEY TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RUSSIAN FEDERATION; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CHILD; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; POINT MUTATION; POLYMERASE CHAIN REACTION; RIFAMPIN; RUSSIA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; TUBERCULOSIS, RENAL;

EID: 0032991030     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cole S. Mycobacterium tuberculosis: drug resistance mechanisms. Trends Microbiol 1994; 2; 411-415.
2. Telzak E, Sepcowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patient without HIV infection. N Engl J Med 1995; 333; 907-911.
3. Drobniewski F, Tayler E, Ignatenko N, et al. Tuberculosis in Siberia: An epidemiological and microbiological assesment. Tubercle Lung Dis 1996; 77; 199-206.
4. Tuberculosis Worldwide Digest of Weekly Epidemiological Reviews 1995; 14-15.
5. Viskum K, Kok-Jensen A. Multidrug-resistant tuberculosis in Denmark 1993-1995. Int J Tuberc Lung Dis 1997; 1; 299-301.
6. Kim S J, Bai G H, Hong Y P. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997; 1; 302-308.
7. Mannheimer S B, Sepkowitz K A, Stoecle M, Friedman C R, Hafner A, Riley L W. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City. Int J Tuberc Lung Dis 1997; 1; 319-325.
8. Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-578.
9. Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74; 5463-5467.
10. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutation in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1993; 341; 647-650.